Alcon

Research reveals dry eye sufferers in the dark on treatment options

Pharmacists are being called upon to help the millions of Australians suffering dry eye disease in the wake of new research that shows 77% have experienced symptoms yet many do not have a clear understanding of the signs, symptoms or causes.
Read More

rhiannon bowmanMay 27, 2022, 8:59 amMay 27, 2022

Clinic becomes Australia’s first to offer latest in LASIK tech

Australian ophthalmology network PersonalEYES has become the nation’s first to offer a breakthrough method of measuring and combining data to generate a multi-dimensional model of the eye for more precise laser eye treatment.
Read More

pcm_adminMarch 22, 2022, 2:26 pmMarch 29, 2022

Alcon announces APAC leadership reshuffle

Alcon has announced two new appointments to lead the company’s surgical and vision care franchises in Asia Pacific (APAC) region.
Read More

Myles HumeJanuary 28, 2022, 6:43 amJanuary 28, 2022

Alcon to acquire Hydrus Microstent MIGS device for AU$640 million

Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device – for an initial US$475 million (AU$640 m).
Read More

pcm_adminNovember 9, 2021, 8:34 amNovember 10, 2021

Operating in a new dimension with 3D visualisation

A new era in ophthalmic surgery has dawned with the emergence of 3D visualisation systems. Surgeons discuss how Alcon’s latest advance in this field is offering new levels of comfort, efficiency and teaching advantages in Australian operating theatres. Read More

Myles HumeMay 24, 2021, 1:39 pmMay 24, 2021

Alcon launches breakthrough Vivity IOL in Australia

Alcon has officially ushered in what some Australian ophthalmologists are calling a new class in presbyopia-correcting intraocular lens (IOL) technology due to its ability to negate visual disturbances – the bane of many EDOF and multifocal IOL designs.
Read More

Myles HumeSeptember 22, 2020, 2:50 pmSeptember 23, 2020

Alcon announces plan for ‘multi-year transformation program’

Alongside its third quarter results for 2019, Alcon has announced a multi-year transformation program to invest in strategic growth initiatives.
Read More

Callum GlennenDecember 11, 2019, 7:45 amDecember 11, 2019

Alcon

Research reveals dry eye sufferers in the dark on treatment options

Clinic becomes Australia’s first to offer latest in LASIK tech

Alcon announces APAC leadership reshuffle

Alcon to acquire Hydrus Microstent MIGS device for AU$640 million

Operating in a new dimension with 3D visualisation

Alcon launches breakthrough Vivity IOL in Australia

Alcon announces plan for ‘multi-year transformation program’

Connect With Us

Join The Newsletter

Popular Topics

About Insight